John G. Boss - 06 Aug 2024 Form 4 Insider Report for Calumet, Inc. /DE (CLMT)

Role
Director
Signature
/s/ Vincent Donargo, as attorney-in-fact
Issuer symbol
CLMT
Transactions as of
06 Aug 2024
Transactions value $
$0
Form type
4
Filing time
08 Aug 2024, 17:49:59 UTC
Previous filing
24 May 2024
Next filing
12 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLMT Restricted Stock Unit Award $0 +1,611 $0 1,611 06 Aug 2024 Common Stock, par value $0.01 per share 1,611 Direct F1, F2
transaction CLMT Restricted Stock Units Award $0 +537 $0 537 06 Aug 2024 Common Stock, par value $0.01 per share 537 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
F2 Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested.
F3 Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2025.

Remarks:

On July 10, 2024, Calumet, Inc. became the successor issuer to, and parent holding company of, Calumet Specialty Products Partners, L.P. (the "Partnership") pursuant to the previously reported corporate reorganization in which all of the Partnership's outstanding common units representing limited partner interests were automatically exchanged into an equal number of shares of Calumet, Inc. common stock, par value $0.01 per share.